Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shruti S. Sawant"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 11, p 1444 (2024)
Background: Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths globally. The most extensive treatment is Tyrosine Kinase Inhibitors (TKIs) that target epidermal growth factor receptor (EGFR) overexpression. Osimertinib, a third-ge
Externí odkaz:
https://doaj.org/article/f5be4429fc584ebebb81337f036d05c5
Autor:
Suyash M. Patil, Snehal K. Shukla, Shruti S. Sawant, Nishant S. Kulkarni, Nitesh K. Kunda, Vivek Gupta
Publikováno v:
Drug Delivery and Translational Research. 12:2474-2487
Osimertinib (OB) is a third-generation irreversible tyrosine kinase inhibitor targeting the epidermal growth factor receptor (EGFR), overexpressed in non-small cell lung cancer. Systemic administration of drug often results in poor drug levels at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::443e02a72eeacca914b9cc817429c294
https://doi.org/10.1007/s13346-021-01088-0
https://doi.org/10.1007/s13346-021-01088-0
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 7575, p 7575 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Conventional anti-cancer therapy involves the use of chemical chemotherapeutics and radiation and are often non-specific in action. The development of drug resistance and the inability of the drug to penetrate the tumor cells has been a major pitfall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9689dfad5d8c3dcc1c05bd76315306
https://www.mdpi.com/1422-0067/21/20/7575
https://www.mdpi.com/1422-0067/21/20/7575
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 154
Exosomes are intracellular membrane-based vesicles with diverse compositions that are involved in biological and pathological processes. Since the discovery of exosomes, they have been used as diagnostic biomarkers and as potential drug delivery vehi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acc4a92ac07ca8a761fef0e214709ee8
https://pubmed.ncbi.nlm.nih.gov/32717385
https://pubmed.ncbi.nlm.nih.gov/32717385
Publikováno v:
International Journal of Pharmaceutics. 607:121046
Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths globally. Treatment-related adverse effects and development of drug resistance limit the available treatment options for most patients. Therefore, newer drug candidates and drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668250320af60adedce149fb48ecc420
https://doi.org/10.1016/j.ijpharm.2021.121046
https://doi.org/10.1016/j.ijpharm.2021.121046
Autor:
Sawant S; Department of Electrical Engineering (EE), IIT Bombay, Powai, Mumbai, 400076, Maharashtra, India. Electronic address: shrutisawant@iitb.ac.in., Sethi A; Department of Electrical Engineering (EE), IIT Bombay, Powai, Mumbai, 400076, Maharashtra, India. Electronic address: asethi@iitb.ac.in., Banerjee S; Department of Civil Engineering (CE), IIT Bombay, Powai, Mumbai, 400076, Maharashtra, India. Electronic address: sauvik@civil.iitb.ac.in., Tallur S; Department of Electrical Engineering (EE), IIT Bombay, Powai, Mumbai, 400076, Maharashtra, India. Electronic address: stallur@ee.iitb.ac.in.
Publikováno v:
Ultrasonics [Ultrasonics] 2023 Apr; Vol. 130, pp. 106931. Date of Electronic Publication: 2023 Jan 19.
Autor:
Sawant S; Department of Electrical Engineering, Indian Institute of Technology Bombay, Mumbai 400076, MH, India., Banerjee S; Department of Civil Engineering, Indian Institute of Technology Bombay, Mumbai 400076, MH, India. Electronic address: sauvik@civil.iitb.ac.in., Tallur S; Department of Electrical Engineering, Indian Institute of Technology Bombay, Mumbai 400076, MH, India. Electronic address: stallur@ee.iitb.ac.in.
Publikováno v:
Ultrasonics [Ultrasonics] 2021 Aug; Vol. 115, pp. 106439. Date of Electronic Publication: 2021 Apr 16.